MedPath

Treatment of Rumination

Not Applicable
Recruiting
Conditions
Rumination Syndrome
Registration Number
NCT06971354
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Brief Summary

Background: Rumination syndrome is characterized by the involuntary regurgitation of previously ingested food from the stomach to the mouth, triggered by an unintentional contraction of the abdominal muscles along with simultaneous relaxation of the esophageal sphincters. Based on this mechanism, a biofeedback technique targeting muscular activity has been developed and shown to be effective. However, such techniques are often complex and not widely accessible.

Hypothesis: Rumination can be effectively treated using a simplified, non-instrumental biofeedback technique based on cognitive intervention.

Objective: To evaluate the effectiveness of a non-instrumental biofeedback technique incorporating cognitive intervention for the treatment of rumination. The methodology will build on prior studies, employing a more streamlined biofeedback approach.

Methods: Participants will be assigned to parallel groups with balanced sex distribution. The study will compare responses to biofeedback versus a control intervention. Over a four-week period, each participant will undergo three treatment sessions:

The biofeedback group will be trained to control abdominothoracic musculature through cognitive intervention, supported by original visual materials, both before and after a standardized test meal.

The control group will receive a placebo capsule prior to the test meal, and regurgitation episodes will be recorded.

Following the initial session, biofeedback participants will continue with daily exercises, while control participants will take a placebo with each meal. Treatment response will be assessed by comparing outcomes before and after the intervention. After post-treatment assessment, control group participants will be offered the opportunity to receive biofeedback therapy.

Relevance: This project aims to determine the efficacy of a simplified mechanistic intervention for rumination. If successful, this approach could be adopted in additional healthcare settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Rumination syndrome
Exclusion Criteria
  • Relevant organic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of rumination events after a challenge meal measured by an event marker.4 weeks

Each regurgitation event will be registered by the patient using an event marker.

Secondary Outcome Measures
NameTimeMethod
Number of self perceived rumination events4 weeks

Number of rumination events measured by questionnaires administered daily for 7 days before and at the end of treatment.

Number of rumination events6 months

Number of rumination events measured by questionnaires administered daily for 7 days, 6 months after treatment.

Quantity of meal regurgitated4 weeks

The quantity of the standardized meal that is regurgitated will be recorded, and the proportion of regurgitated to ingested meal will be calculated.

Trial Locations

Locations (1)

Vall d'Hebron Research Institute

🇪🇸

Barcelona, Spain

Vall d'Hebron Research Institute
🇪🇸Barcelona, Spain
Jordi Serra, M.D.
Contact
34 93 274 6259
jordi.serra@vallhebron.cat

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.